Clinical Trial Update: Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines [Phase 3]

View source ↗

Summary

This Phase 3 trial is evaluating whether adding magnesium to prochlorperazine improves treatment outcomes for migraines, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Magnesium (magnesium)
• prochlorperazine (prochlorperazine)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Migraine | Phase 3 | Status: RECRUITING